Accuryn Medical
PrivateLast Round
Private Equity
Feb 8, 2024
Est. Valuation
$122.54M
Total Funding Raised
$103.25M
Company Overview
Accuryn Medical operates in Healthcare & Life Sciences and is based in Hayward, California. Its latest recorded funding round was a Private Equity round in February 2024.
Accuryn Medical is a healthcare technology company that develops a predictive health monitoring system for critical care settings, utilizing smart sensors and artificial intelligence to automate urine output, intra-abdominal pressure, and core body temperature measurements.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Accuryn Medical Comparables
Compare Accuryn Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CardioRenal Systems | 87% | |
| Fize Medical | 85% | |
| RenalSense Ltd. | 83% |
For institutional investors. Book with your work email.
Accuryn Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Feb 8, 2024 | ||||
| Series D | Apr 7, 2023 | ||||
| Series C Extension | Oct 29, 2019 | ||||
| Series C Extension | Jul 12, 2019 | ||||
| Series C | Jul 9, 2018 | ||||
Series B | Aug 7, 2017 |
For institutional investors. Book with your work email.
Accuryn Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Scientific Health Development | Seed, Series D |
| NIH RADx | Grant |
| TheraNova | Seed |
| U.S. Department of War | Grant |
| GT Healthcare Capital Partners | Series C |
| Sonder Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 21, 2025
Todd Dunn appointed as the new Chief Executive Officer.
- Feb 8, 2024
Raised $10M in a Private Equity round.
For institutional investors. Book with your work email.
Accuryn Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Accuryn Medical's valuation, stock price, and market status.
Is Accuryn Medical a public or private company?
Accuryn Medical is a private company.
What is the current stock price of Accuryn Medical?
Accuryn Medical is a private company, so its shares have no public market price. Caplight tracks Accuryn Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Accuryn Medical worth (valuation)?
Accuryn Medical's valuation is estimated at $122.5M based on funding round data.
Can I buy Accuryn Medical stock?
Accuryn Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Accuryn Medical's last funding round?
Accuryn Medical's most recent funding round was Private Equity on February 8, 2024.
Who are the main investors in Accuryn Medical?
Key investors in Accuryn Medical include GT Healthcare Capital Partners, Sonder Capital.
Will Accuryn Medical IPO soon?
No public IPO plans have been announced for Accuryn Medical.
How can I track Accuryn Medical secondary market activity?
Caplight tracks bids, offers, and trades in Accuryn Medical's shares on secondary markets.